DocGo Inc. Payments to Acquire Productive Assets
DocGo Inc. (DCGO) reported Payments to Acquire Productive Assets of $4.23 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2024-11-07
- DocGo Inc. payments to acquire productive assets for the quarter ending 2024-09-30 was $4.23M, a 22.97% decline year-over-year.
- DocGo Inc. payments to acquire productive assets for the quarter ending 2024-06-30 was $4.82M, a 0.49% increase year-over-year.
- DocGo Inc. payments to acquire productive assets for the quarter ending 2024-03-31 was $4.14M, a 86.75% decline year-over-year.
- DocGo Inc. payments to acquire productive assets for the quarter ending 2023-12-31 was $3.29M, a 95.57% decline year-over-year.
- DocGo Inc. payments to acquire productive assets for fiscal 2023 was $51.02M, a 45.85% decline from fiscal 2022.
- DocGo Inc. payments to acquire productive assets for fiscal 2022 was $94.22M, a 407.02% increase from fiscal 2021.
- DocGo Inc. payments to acquire productive assets for fiscal 2021 was $18.58M.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2024-09-30 | $4.23M 10-Q · filed 2024-11-07 | $9.05M derived: sum of 2 quarters · filed 2024-11-07 | $13.19M 10-Q · filed 2024-11-07 | $16.47M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | $4.82M 10-Q · filed 2024-08-07 | $8.95M 10-Q · filed 2024-08-07 | $12.24M derived: sum of 3 quarters · filed 2024-08-07 | $17.73M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | $4.14M 10-Q · filed 2024-05-08 | $7.42M derived: sum of 2 quarters · filed 2024-05-08 | $12.91M derived: sum of 3 quarters · filed 2024-11-07 | $17.71M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $8.78M derived: sum of 2 quarters · filed 2024-11-07 | $13.57M derived: sum of 3 quarters · filed 2024-11-07 | $51.02M 10-K · filed 2024-02-28 |
| 2023-09-30 | $5.49M 10-Q · filed 2024-11-07 | $10.29M derived: sum of 2 quarters · filed 2024-11-07 | $47.73M 10-Q · filed 2024-11-07 | $115.61M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $4.80M 10-Q · filed 2024-08-07 | $42.64M 10-Q · filed 2024-08-07 | $110.12M derived: sum of 3 quarters · filed 2024-08-07 | $127.47M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $31.22M 10-Q · filed 2024-05-08 | $105.32M derived: sum of 2 quarters · filed 2024-05-08 | $122.68M derived: sum of 3 quarters · filed 2024-05-08 | $147.89M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $74.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $91.46M derived: sum of 2 quarters · filed 2024-02-28 | $116.68M derived: sum of 3 quarters · filed 2024-02-28 | $94.22M 10-K · filed 2024-02-28 |
| 2022-09-30 | $17.35M 10-Q · filed 2023-11-06 | $42.57M derived: sum of 2 quarters · filed 2023-11-06 | $20.11M 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $25.21M 10-Q · filed 2023-08-08 | $26.93M 10-Q · filed 2023-08-08 | ||
| 2021-12-31 | $18.58M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |